Northwest Bancshares, Inc. Eli Lilly & CO Transaction History

Northwest Bancshares, Inc.

$585 Million
Q3 2024

A detailed history of Northwest Bancshares, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Northwest Bancshares, Inc. holds 4,886 shares of LLY stock, worth $3.86 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

4,886

Previous 5,113 4.44%

Holding current value

$3.86 Million

Previous $4.63 Million 6.5%

% of portfolio

0.74%

Previous 0.79%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $175,275 - $217,924	-227 Reduced 4.44%	4,886 $4.33 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $529,879 - $664,508	-731 Reduced 12.51%	5,113 $4.63 Million
Q1 2024 Apr 26, 2024	BUY	$592.2 - $792.28 $158,709 - $212,331	268 Added 4.81%	5,844 $4.55 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $265,220 - $312,660	-505 Reduced 8.3%	5,576 $3.25 Million
Q3 2023 Oct 27, 2023	BUY	$434.7 - $599.3 $116,499 - $160,612	268 Added 4.61%	6,081 $3.27 Million
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $41,738 - $55,808	-119 Reduced 2.01%	5,813 $2.73 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $114,311 - $134,253	-368 Reduced 5.84%	5,932 $2.04 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $4,823 - $5,620	-15 Reduced 0.24%	6,300 $2.3 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $609,562 - $694,660	-2,056 Reduced 24.56%	6,315 $2.04 Million
Q2 2022 Aug 16, 2022	SELL	$278.73 - $327.27 $172,812 - $202,907	-620 Reduced 6.9%	8,371 $2.71 Million
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $68,060 - $84,581	-290 Reduced 3.12%	8,991 $2.58 Million
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $22,160 - $27,270	-100 Reduced 1.07%	9,281 $2.15 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $27,082 - $35,031	-150 Reduced 1.57%	9,381 $2.15 Million
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $35,493 - $45,947	-216 Reduced 2.22%	9,531 $1.78 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $12,002 - $15,881	-92 Reduced 0.94%	9,747 $1.65 Million
Q3 2020 Oct 20, 2020	SELL	$146.22 - $169.13 $62,143 - $71,880	-425 Reduced 4.14%	9,839 $1.46 Million
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $160,293 - $192,911	1,175 Added 12.93%	10,264 $1.69 Million
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $107,740 - $133,351	-905 Reduced 9.06%	9,089 $1.26 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $59,661 - $73,895	-558 Reduced 5.29%	9,994 $1.31 Million
Q3 2019 Oct 09, 2019	SELL	$106.79 - $116.16 $7,154 - $7,782	-67 Reduced 0.63%	10,552 $1.18 Million
Q2 2019 Jul 17, 2019	BUY	$110.79 - $129.32 $3,212 - $3,750	29 Added 0.27%	10,619 $1.18 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $30,816 - $34,524	-291 Reduced 2.67%	10,590 $1.23 Million
Q3 2018 Oct 02, 2018	BUY	$85.86 - $107.31 $10,732 - $13,413	125 Added 1.16%	10,881 $1.17 Million
Q2 2018 Aug 09, 2018	SELL	$75.7 - $86.88 $22,710 - $26,064	-300 Reduced 2.71%	10,756 $918,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $905,928 - $971,711	11,056	11,056 $934,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bancshares, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bancshares, Inc. with notifications on news.

Account

Northwest Bancshares, Inc. Eli Lilly & CO Transaction History